治疗前去脂体重指数与头颈部鳞状细胞癌患者早期死亡相关
研究前瞻性纳入404例新诊断、可治愈且WHO体能状态0-2分的头颈部鳞状细胞癌(HNSCC)患者,在治疗前进行生物电阻抗分析并计算去脂体重指数(FFMI)与体重指数(BMI)。结果显示,治疗前FFMI是治疗开始后6个月和12个月内死亡的独立预后因素,而治疗前BMI不是独立危险因素。
要点
- 治疗前FFMI是HNSCC患者治疗开始后6个月和12个月内死亡的独立预后因素。
- 治疗前BMI不是治疗结束后6个月和12个月内死亡的独立危险因素。
- FFMI可能有助于头颈部癌症患者的风险分层。
核心结论
- 治疗前FFMI是HNSCC患者治疗开始后6个月和12个月内死亡的独立预后因素。
- 治疗前BMI不是治疗结束后6个月和12个月内死亡的独立危险因素。
- FFMI可能有助于头颈部癌症患者的风险分层。
研究设计与样本
- 前瞻性纳入404例新诊断、可治愈且WHO体能状态0-2分的HNSCC患者,治疗开始前与研究代表会面并进行最多四次随访。
- 所有患者在治疗开始前进行生物电阻抗分析(BIA),并提供诊断前6个月的体重估计值。
主要发现
- 大多数患者为口咽癌(46%)、口腔癌(28%)或喉癌(12%)。
- 45例(11%)患者在诊断时符合全球营养不良领导倡议(GLIM)的标准化营养不良标准。
- 治疗开始后6个月内死亡的患者诊断时FFMI低于存活超过6个月的患者(p=0.035)。
- 治疗开始后12个月内死亡的患者诊断时FFMI低于存活超过12个月的患者(p=0.005)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A significant proportion of patients with head and neck squamous cell carcinoma (HNSCC) are malnourished at diagnosis. In this study, we investigated how pretreatment body mass index (BMI) and fat-free mass index (FFMI) correlate with early death, and whether these measurements are useful markers of prognosis for risk stratification of head and neck cancer patients. METHODS: Patients (n = 404) with newly diagnosed, curable HNSCC and WHO performance status 0-2 were prospectively included and met with a study representative before treatment initiation, as well as up to four follow-up visits. All patients provided an estimate of body weight at 6 months prior to diagnosis. Bioelectrical impedance analysis (BIA) was performed for all patients before treatment initiation. RESULTS: Most patients had oropharyngeal (46%), oral cavity (28%), or laryngeal cancer (12%). Forty-five (11%) patients met the standardized criteria for malnutrition according to the Global Leadership Initiative on Malnutrition (GLIM) at diagnosis. FFMI at diagnosis was lower in patients who died within 6 and 12 months after the start of treatment than in patients who survived these time points (p = 0.035 and p = 0.005, respectively). CONCLUSIONS: In this study, pretreatment FFMI was an independent prognostic factor for death within 6 and 12 months after the start of treatment in patients with HNSCC. Pretreatment BMI was not an independent risk factor for death within 6 and 12 months after treatment termination. Thus, FFMI may be useful for risk stratification of patients with head and neck cancer.
引用
- Talani C, Astradsson T, Farnebo L, et al. Pretreatment fat-free mass index correlates with early death in patients with head and neck squamous cell carcinoma. Head Neck. 2024. PMID: 38193618. doi:10.1002/hed.27628
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。